ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,795
0,20%
Bitcoin
59 741,61
1,05%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Ionis Pharmaceuticals Inc (IONS)

  7. Ionis Pharmaceuticals Inc (IONS) Actualités

IONS Ionis Pharmaceuticals Inc

43,09
0,08 (0,19%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Ionis Pharmaceuticals Inc IONS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,08 0,19% 43,09 23:30:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
43,15 42,62 43,62 43,09 43,01
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202413:00PRNUSIonis Publishes 2023 Corporate Responsibility Report
23/4/202413:05PRNUSIonis to hold first quarter 2024 financial results webcast
07/4/202415:48PRNUSIonis presents positive results from Phase 3 Balance study..
01/4/202413:05PRNUSIonis to present at upcoming investor conferences
28/3/202412:05PRNUSIonis to hold olezarsen Phase 3 data webcast
25/3/202413:18PRNUSPositive olezarsen Phase 3 data in familial chylomicronemia..
13/3/202412:00PRNUSIonis announces positive results from Phase 2 study of..
06/3/202413:30GLOBENew Biomarker Data Add Further Evidence Supporting the..
05/3/202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202415:10EDGAR2Form 8-K - Current report
29/2/202415:05PRNUSIonis announces new chief global product strategy officer to..
28/2/202413:05PRNUSIonis to present at upcoming investor conferences
21/2/202417:17EDGAR2Form 8-K - Current report
21/2/202413:00PRNUSIonis reports fourth quarter and full year 2023 financial..
20/2/202416:39EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
17/2/202401:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:34EDGAR2Form 144 - Report of proposed sale of securities
15/2/202413:00PRNUSOlezarsen receives Orphan Drug designation from U.S. FDA for..
14/2/202416:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202412:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202413:00PRNUSEplontersen granted U.S. FDA Fast Track designation for..
07/2/202413:05PRNUSIonis to hold fourth quarter and full year 2023 financial..
03/2/202401:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202401:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202401:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202401:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202401:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202423:34EDGAR2Form 144 - Report of proposed sale of securities
02/2/202423:31EDGAR2Form 144 - Report of proposed sale of securities
02/2/202423:30EDGAR2Form 144 - Report of proposed sale of securities
02/2/202423:28EDGAR2Form 144 - Report of proposed sale of securities
02/2/202423:25EDGAR2Form 144 - Report of proposed sale of securities
02/2/202423:23EDGAR2Form 144 - Report of proposed sale of securities
02/2/202423:21EDGAR2Form 144 - Report of proposed sale of securities
02/2/202423:19EDGAR2Form 144 - Report of proposed sale of securities
01/2/202403:30EDGAR2Form 144 - Report of proposed sale of securities
29/1/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202420:37EDGAR2Form 144 - Report of proposed sale of securities
26/1/202420:09EDGAR2Form 144 - Report of proposed sale of securities
22/1/202413:10EDGAR2Form 8-K - Current report
22/1/202413:00PRNUSIonis announces positive topline results from Phase 3..
19/1/202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
IONS
Ionis Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés